There's reassuring news for pregnant women miserable with morning sickness: A very large study in Denmark finds no evidence that using a popular anti-nausea drug will harm their babies.
One in 10 pregnant women has nausea and vomiting bad enough to need medicine but many forgo it out of fear of side effects. No drugs are currently approved for morning sickness in the United States although doctors are free to prescribe whatever they believe is best.
Zofran, sold by GlaxoSmithKline and in generic form for treating nausea from cancer treatments and other causes, has been the top choice. Yet women and doctors have been leery of it because a small study previously suggested it might raise the risk of a birth defect — cleft palate.
The new study of more than 600,000 pregnancies in Denmark found no evidence of major birth-related problems, so women should not be afraid to use Zofran if they need it, said Dr. Iffath Hoskins, a high-risk pregnancy specialist at NYU Langone Medical Center and a spokeswoman for the American College of Obstetricians and Gynecologists.
"It's effective and it's safe," she said. Poor nutrition because of excessive vomiting can harm the woman and fetus, she added.
Hoskins had no role in the study, which was led by Dr. Bjorn Pasternak of the State Serum Institute in Copenhagen. Results appear in Thursday's New England Journal of Medicine.
- As Ferguson verdict is read, protesters in...
- Grand jury won't indict Ferguson cop in shooting
- Ferguson businesses torched in overnight...
- Why Salt Lake City is one of the best cities...
- Reports: Ferguson grand jury has reached...
- Under pressure, Hagel steps down as Pentagon...
- At least 17 killed in Egypt by building collapse
- In New Zealand, feud over fate of 1902 corpse...
- President Obama's immigration reforms... 65
- As Ferguson verdict is read, protesters... 56
- Pastors opposed to same-sex marriage... 45
- Obama: Americans want 'new car smell'... 29
- Grand jury won't indict Ferguson cop in... 24
- Fact check: Obama's claims on illegal... 18
- Winners and losers under Obama's... 18
- Under pressure, Hagel steps down as... 15